Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 22 | 2015 | 187 | 2.570 |
Why?
|
| Wills | 4 | 2013 | 5 | 1.150 |
Why?
|
| Geriatric Psychiatry | 14 | 2021 | 18 | 1.140 |
Why?
|
| Alzheimer Disease | 14 | 2004 | 470 | 1.120 |
Why?
|
| Antipsychotic Agents | 8 | 2005 | 123 | 1.020 |
Why?
|
| Mental Competency | 4 | 2013 | 49 | 0.980 |
Why?
|
| Geriatric Assessment | 9 | 2009 | 166 | 0.910 |
Why?
|
| Expert Testimony | 4 | 2013 | 46 | 0.870 |
Why?
|
| Antidepressive Agents | 7 | 2004 | 106 | 0.870 |
Why?
|
| Psychotic Disorders | 5 | 2021 | 184 | 0.820 |
Why?
|
| Mental Disorders | 10 | 2004 | 371 | 0.820 |
Why?
|
| Sertraline | 4 | 2004 | 7 | 0.650 |
Why?
|
| Aged | 58 | 2015 | 18415 | 0.640 |
Why?
|
| Depressive Disorder | 7 | 2001 | 218 | 0.580 |
Why?
|
| Delirium | 2 | 2013 | 66 | 0.540 |
Why?
|
| Caregivers | 3 | 2007 | 151 | 0.510 |
Why?
|
| Psychiatric Status Rating Scales | 8 | 2004 | 487 | 0.490 |
Why?
|
| Behavioral Symptoms | 2 | 2004 | 15 | 0.480 |
Why?
|
| Terminally Ill | 1 | 2013 | 23 | 0.470 |
Why?
|
| Aged, 80 and over | 26 | 2015 | 6509 | 0.460 |
Why?
|
| Primary Health Care | 3 | 2003 | 339 | 0.410 |
Why?
|
| Depressive Disorder, Major | 2 | 2007 | 158 | 0.410 |
Why?
|
| Neuropsychological Tests | 10 | 2015 | 502 | 0.390 |
Why?
|
| Risperidone | 3 | 2005 | 23 | 0.370 |
Why?
|
| Cognition Disorders | 3 | 2015 | 236 | 0.340 |
Why?
|
| Nursing Homes | 5 | 2000 | 109 | 0.330 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2004 | 45 | 0.310 |
Why?
|
| Telecommunications | 1 | 2007 | 7 | 0.310 |
Why?
|
| Patient Care Team | 3 | 2003 | 280 | 0.310 |
Why?
|
| Humans | 68 | 2021 | 86643 | 0.290 |
Why?
|
| Social Behavior Disorders | 2 | 1996 | 19 | 0.280 |
Why?
|
| Depression | 3 | 2003 | 473 | 0.280 |
Why?
|
| Serotonin Antagonists | 1 | 2004 | 35 | 0.250 |
Why?
|
| Internet | 1 | 2007 | 312 | 0.250 |
Why?
|
| Phenylcarbamates | 1 | 2004 | 6 | 0.250 |
Why?
|
| Cerebrovascular Disorders | 1 | 2005 | 143 | 0.250 |
Why?
|
| Physician's Role | 2 | 2003 | 179 | 0.250 |
Why?
|
| Carbamates | 1 | 2004 | 19 | 0.250 |
Why?
|
| Aging | 6 | 2006 | 691 | 0.240 |
Why?
|
| Homes for the Aged | 4 | 2000 | 26 | 0.240 |
Why?
|
| Clinical Trials as Topic | 6 | 2004 | 1169 | 0.240 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 94 | 0.240 |
Why?
|
| Case Management | 1 | 2003 | 24 | 0.230 |
Why?
|
| Congresses as Topic | 1 | 2003 | 116 | 0.210 |
Why?
|
| Psychotropic Drugs | 2 | 2003 | 75 | 0.200 |
Why?
|
| Psychomotor Agitation | 3 | 2001 | 26 | 0.190 |
Why?
|
| Telemedicine | 1 | 2003 | 169 | 0.190 |
Why?
|
| Male | 31 | 2015 | 40965 | 0.190 |
Why?
|
| Treatment Outcome | 9 | 2007 | 7993 | 0.190 |
Why?
|
| Frail Elderly | 3 | 2003 | 71 | 0.190 |
Why?
|
| Female | 34 | 2015 | 44532 | 0.190 |
Why?
|
| Patient Admission | 2 | 2005 | 112 | 0.190 |
Why?
|
| Nortriptyline | 1 | 1999 | 6 | 0.170 |
Why?
|
| Coercion | 2 | 2009 | 15 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 132 | 0.170 |
Why?
|
| Behavior | 3 | 1996 | 85 | 0.170 |
Why?
|
| Fluoxetine | 1 | 1999 | 42 | 0.170 |
Why?
|
| Benzodiazepines | 3 | 2005 | 65 | 0.170 |
Why?
|
| Managed Care Programs | 2 | 2003 | 42 | 0.160 |
Why?
|
| United States | 14 | 2015 | 6672 | 0.160 |
Why?
|
| Health Services Needs and Demand | 2 | 1992 | 102 | 0.150 |
Why?
|
| Malpractice | 1 | 1997 | 57 | 0.150 |
Why?
|
| Thiothixene | 1 | 1996 | 1 | 0.140 |
Why?
|
| Neurocognitive Disorders | 1 | 1996 | 13 | 0.140 |
Why?
|
| Double-Blind Method | 6 | 2004 | 1823 | 0.140 |
Why?
|
| Health Care Reform | 1 | 1997 | 90 | 0.140 |
Why?
|
| Physical Examination | 1 | 1997 | 149 | 0.140 |
Why?
|
| Quetiapine Fumarate | 2 | 2005 | 4 | 0.130 |
Why?
|
| Dibenzothiazepines | 2 | 2005 | 4 | 0.130 |
Why?
|
| Activities of Daily Living | 4 | 2001 | 204 | 0.130 |
Why?
|
| Middle Aged | 17 | 2015 | 25028 | 0.130 |
Why?
|
| Suicide | 2 | 1995 | 139 | 0.130 |
Why?
|
| Memory Disorders | 1 | 2015 | 69 | 0.130 |
Why?
|
| Thiazoles | 2 | 2005 | 131 | 0.120 |
Why?
|
| Psychotherapy, Group | 2 | 1990 | 33 | 0.120 |
Why?
|
| Mental Status Schedule | 2 | 1993 | 26 | 0.120 |
Why?
|
| Schizophrenia | 4 | 2001 | 464 | 0.120 |
Why?
|
| Home Care Services | 3 | 2003 | 72 | 0.120 |
Why?
|
| Ethics, Clinical | 1 | 2013 | 48 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2007 | 839 | 0.120 |
Why?
|
| Piperazines | 2 | 2005 | 272 | 0.120 |
Why?
|
| Community Health Services | 2 | 2007 | 80 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 1996 | 306 | 0.110 |
Why?
|
| Cognition | 4 | 2004 | 570 | 0.110 |
Why?
|
| Eligibility Determination | 1 | 1992 | 32 | 0.110 |
Why?
|
| Research Design | 1 | 1996 | 594 | 0.110 |
Why?
|
| Terminal Care | 1 | 2013 | 130 | 0.110 |
Why?
|
| Clozapine | 2 | 2004 | 9 | 0.100 |
Why?
|
| Age Factors | 6 | 2015 | 1851 | 0.100 |
Why?
|
| Sleep | 2 | 2006 | 444 | 0.100 |
Why?
|
| Schizophrenic Psychology | 3 | 2000 | 129 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2007 | 1801 | 0.100 |
Why?
|
| Circadian Rhythm | 3 | 2004 | 303 | 0.100 |
Why?
|
| Paranoid Disorders | 1 | 1990 | 5 | 0.100 |
Why?
|
| Medical Informatics | 1 | 1991 | 47 | 0.090 |
Why?
|
| Mass Screening | 1 | 2015 | 618 | 0.090 |
Why?
|
| Quality of Life | 4 | 2006 | 1585 | 0.090 |
Why?
|
| House Calls | 1 | 1990 | 9 | 0.090 |
Why?
|
| Publishing | 1 | 1991 | 90 | 0.090 |
Why?
|
| Mental Health | 2 | 2006 | 162 | 0.090 |
Why?
|
| Medicaid | 1 | 1992 | 217 | 0.090 |
Why?
|
| Forensic Psychiatry | 1 | 2009 | 5 | 0.090 |
Why?
|
| Exercise | 2 | 2004 | 315 | 0.090 |
Why?
|
| Elder Abuse | 1 | 2008 | 1 | 0.090 |
Why?
|
| Living Wills | 1 | 2008 | 4 | 0.090 |
Why?
|
| Memory | 2 | 2004 | 225 | 0.090 |
Why?
|
| Bronchogenic Cyst | 1 | 1988 | 5 | 0.080 |
Why?
|
| Medicare | 1 | 1992 | 410 | 0.080 |
Why?
|
| Computer-Assisted Instruction | 1 | 1989 | 43 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 1991 | 168 | 0.080 |
Why?
|
| Psychiatry | 2 | 2001 | 78 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 1961 | 0.080 |
Why?
|
| Research | 3 | 1996 | 253 | 0.080 |
Why?
|
| Cost of Illness | 2 | 2007 | 150 | 0.080 |
Why?
|
| Stomach | 1 | 1988 | 108 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 162 | 0.080 |
Why?
|
| Social Work | 1 | 2007 | 19 | 0.080 |
Why?
|
| Haloperidol | 1 | 2005 | 30 | 0.070 |
Why?
|
| Aripiprazole | 1 | 2004 | 5 | 0.060 |
Why?
|
| Social Behavior | 3 | 2000 | 294 | 0.060 |
Why?
|
| Anxiety Disorders | 2 | 1992 | 148 | 0.060 |
Why?
|
| Rivastigmine | 1 | 2004 | 4 | 0.060 |
Why?
|
| Quinolones | 1 | 2004 | 60 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 1 | 2004 | 87 | 0.060 |
Why?
|
| Health Status | 1 | 2006 | 360 | 0.060 |
Why?
|
| Nootropic Agents | 1 | 2004 | 10 | 0.060 |
Why?
|
| Electroshock | 1 | 2003 | 17 | 0.060 |
Why?
|
| Indans | 1 | 2004 | 31 | 0.060 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 1996 | 19 | 0.060 |
Why?
|
| Capitation Fee | 1 | 2003 | 2 | 0.060 |
Why?
|
| Drug Evaluation | 1 | 2003 | 141 | 0.060 |
Why?
|
| Spouses | 1 | 2003 | 33 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2004 | 181 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2003 | 3640 | 0.050 |
Why?
|
| Piperidines | 1 | 2004 | 181 | 0.050 |
Why?
|
| Risk Factors | 3 | 2005 | 5417 | 0.050 |
Why?
|
| Hospitalization | 2 | 2005 | 849 | 0.050 |
Why?
|
| Counseling | 1 | 2003 | 145 | 0.050 |
Why?
|
| Health Services Research | 1 | 1982 | 136 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 894 | 0.050 |
Why?
|
| Disease Management | 1 | 2003 | 327 | 0.050 |
Why?
|
| Cross-Cultural Comparison | 2 | 2001 | 34 | 0.050 |
Why?
|
| Delusions | 1 | 2001 | 11 | 0.050 |
Why?
|
| Hallucinations | 1 | 2001 | 27 | 0.050 |
Why?
|
| Consultants | 1 | 1980 | 7 | 0.050 |
Why?
|
| Psychometrics | 3 | 2001 | 327 | 0.050 |
Why?
|
| Research Personnel | 1 | 2001 | 67 | 0.050 |
Why?
|
| Cross-Over Studies | 2 | 2004 | 399 | 0.050 |
Why?
|
| Mental Health Services | 1 | 1980 | 48 | 0.050 |
Why?
|
| Sleep Stages | 1 | 2000 | 45 | 0.050 |
Why?
|
| Adult | 7 | 2015 | 25648 | 0.050 |
Why?
|
| Nimodipine | 1 | 1999 | 11 | 0.050 |
Why?
|
| Melatonin | 1 | 1999 | 47 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 1997 | 2705 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 335 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2000 | 1565 | 0.040 |
Why?
|
| Forecasting | 2 | 1991 | 304 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2000 | 312 | 0.040 |
Why?
|
| Syndrome | 1 | 2000 | 446 | 0.040 |
Why?
|
| Lorazepam | 1 | 1978 | 16 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 1999 | 153 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2005 | 2767 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2001 | 238 | 0.040 |
Why?
|
| Anti-Anxiety Agents | 1 | 1978 | 23 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1999 | 203 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 2003 | 274 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2003 | 556 | 0.040 |
Why?
|
| Pirenzepine | 1 | 1997 | 8 | 0.040 |
Why?
|
| Psychotherapy | 3 | 1997 | 74 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2010 | 8489 | 0.040 |
Why?
|
| Weight Loss | 1 | 1999 | 229 | 0.040 |
Why?
|
| Decision Making | 1 | 2003 | 642 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 1999 | 912 | 0.040 |
Why?
|
| Heart Rate | 1 | 1999 | 492 | 0.040 |
Why?
|
| Thromboembolism | 1 | 1997 | 119 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 1997 | 220 | 0.030 |
Why?
|
| Diagnosis-Related Groups | 1 | 1995 | 20 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2010 | 4213 | 0.030 |
Why?
|
| Hypertension | 1 | 2003 | 1141 | 0.030 |
Why?
|
| Anticoagulants | 1 | 1997 | 408 | 0.030 |
Why?
|
| Mental Recall | 2 | 2000 | 159 | 0.030 |
Why?
|
| Curriculum | 1 | 1978 | 539 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2003 | 1373 | 0.030 |
Why?
|
| Personality Disorders | 1 | 1995 | 146 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 1995 | 197 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 567 | 0.030 |
Why?
|
| Health Services for the Aged | 2 | 1997 | 27 | 0.030 |
Why?
|
| Molecular Biology | 1 | 1993 | 89 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 1992 | 27 | 0.030 |
Why?
|
| Recurrence | 1 | 1995 | 1139 | 0.030 |
Why?
|
| Specialization | 1 | 1992 | 65 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1992 | 81 | 0.030 |
Why?
|
| Length of Stay | 1 | 1995 | 702 | 0.030 |
Why?
|
| Geriatrics | 1 | 1992 | 61 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 1978 | 827 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 1992 | 186 | 0.020 |
Why?
|
| Observer Variation | 1 | 1993 | 602 | 0.020 |
Why?
|
| Comorbidity | 1 | 1995 | 943 | 0.020 |
Why?
|
| Information Services | 1 | 1991 | 23 | 0.020 |
Why?
|
| Medicine | 1 | 1992 | 89 | 0.020 |
Why?
|
| Fraud | 1 | 2010 | 6 | 0.020 |
Why?
|
| Illinois | 2 | 2003 | 462 | 0.020 |
Why?
|
| Germany | 2 | 2001 | 72 | 0.020 |
Why?
|
| Long-Term Care | 1 | 1990 | 61 | 0.020 |
Why?
|
| Gastric Fistula | 1 | 1988 | 5 | 0.020 |
Why?
|
| Chronic Disease | 1 | 1992 | 971 | 0.020 |
Why?
|
| Diaphragm | 1 | 1988 | 50 | 0.020 |
Why?
|
| Internship and Residency | 1 | 1978 | 1004 | 0.020 |
Why?
|
| International Cooperation | 1 | 2008 | 127 | 0.020 |
Why?
|
| Chicago | 1 | 1993 | 1379 | 0.020 |
Why?
|
| Family Practice | 2 | 1997 | 84 | 0.020 |
Why?
|
| Radiography | 1 | 1988 | 813 | 0.020 |
Why?
|
| Administration, Oral | 2 | 1997 | 684 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 177 | 0.020 |
Why?
|
| Peer Review | 1 | 1986 | 24 | 0.020 |
Why?
|
| Health Behavior | 1 | 2006 | 183 | 0.020 |
Why?
|
| Colonic Polyps | 1 | 1986 | 126 | 0.020 |
Why?
|
| Colonoscopy | 1 | 1986 | 264 | 0.010 |
Why?
|
| Space Perception | 1 | 2004 | 115 | 0.010 |
Why?
|
| Cost Control | 1 | 2003 | 44 | 0.010 |
Why?
|
| Patient Care Management | 1 | 2003 | 31 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 2003 | 30 | 0.010 |
Why?
|
| Affect | 1 | 2004 | 386 | 0.010 |
Why?
|
| Placebos | 2 | 1980 | 218 | 0.010 |
Why?
|
| France | 1 | 2001 | 47 | 0.010 |
Why?
|
| Community Psychiatry | 1 | 1980 | 1 | 0.010 |
Why?
|
| Choline | 1 | 1980 | 23 | 0.010 |
Why?
|
| Attitude of Health Personnel | 2 | 1978 | 636 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 455 | 0.010 |
Why?
|
| Polysomnography | 1 | 2000 | 151 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2006 | 2501 | 0.010 |
Why?
|
| Light | 1 | 1999 | 289 | 0.010 |
Why?
|
| Central Nervous System Agents | 1 | 1997 | 15 | 0.010 |
Why?
|
| Policy Making | 1 | 1997 | 62 | 0.010 |
Why?
|
| Greece | 1 | 1997 | 19 | 0.010 |
Why?
|
| Russia | 1 | 1997 | 25 | 0.010 |
Why?
|
| Health Resources | 1 | 1997 | 76 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1997 | 248 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1997 | 118 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 1673 | 0.010 |
Why?
|
| Physician-Patient Relations | 2 | 1992 | 610 | 0.010 |
Why?
|
| Health Policy | 1 | 1997 | 180 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1997 | 328 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1997 | 229 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 1997 | 394 | 0.010 |
Why?
|
| Prevalence | 1 | 1997 | 1239 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 1978 | 426 | 0.010 |
Why?
|
| Sick Role | 1 | 1992 | 13 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 1992 | 74 | 0.010 |
Why?
|
| Role | 1 | 1971 | 11 | 0.010 |
Why?
|
| Hospitals, Psychiatric | 1 | 1971 | 22 | 0.010 |
Why?
|
| Europe | 1 | 1992 | 309 | 0.010 |
Why?
|
| Personnel, Hospital | 1 | 1971 | 30 | 0.010 |
Why?
|
| Alcoholism | 1 | 1992 | 172 | 0.010 |
Why?
|
| Health Promotion | 1 | 1992 | 160 | 0.010 |
Why?
|
| Time Factors | 1 | 1978 | 5210 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1992 | 302 | 0.010 |
Why?
|
| Sex Factors | 1 | 1992 | 1054 | 0.010 |
Why?
|
| Education, Medical | 1 | 1992 | 233 | 0.010 |
Why?
|
| Motivation | 1 | 1971 | 287 | 0.000 |
Why?
|
| Incidence | 1 | 1992 | 1577 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 1992 | 1621 | 0.000 |
Why?
|